Patents by Inventor FÉLIX CHAGNON

FÉLIX CHAGNON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Steroid alkaloids and compositions and kits thereof
    Patent number: 10716797
    Abstract: The present invention provides bacterial ATP synthase inhibitors such as a compound of formula (I): There are provided compositions and kits using such compounds and inhibitors.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: July 21, 2020
    Assignee: SOCPRA SCIENCES ET GÉNIE S.E.C.
    Inventors: Éric Marsault, François Malouin, Félix Chagnon, Isabelle Guay, Simon Boulanger
  • STEROID ALKALOIDS AND COMPOSITIONS AND KITS THEREOF
    Publication number: 20190008875
    Abstract: The present invention provides bacterial ATP synthase inhibitors such as a compound of formula (I): There are provided compositions and kits using such compounds and inhibitors.
    Type: Application
    Filed: September 20, 2018
    Publication date: January 10, 2019
    Inventors: ÉRIC MARSAULT, FRANÇOIS MALOUIN, FÉLIX CHAGNON, ISABELLE GUAY, SIMON BOULANGER
  • ATP synthase inhibitors and steroid alkaloids and uses thereof as antimicrobial agents and as potentiators for aminoglycosides against pathogenic bacteria
    Patent number: 10137137
    Abstract: The present invention provides bacterial ATP synthase inhibitors such as a compound of formula (I): (Formula (I)) (A) in combination with an aminoglycoside antibiotic for preventing or treating a bacterial infection in a subject; or (B) (a) for preventing or treating an infection caused by an electron transport-deficient bacteria in a subject; or (b) for the disinfection, sterilization and/or antisepsis of an object contaminated with an electron transport-deficient bacteria. There are provided compositions and kits using such compounds and inhibitors.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: November 27, 2018
    Assignee: Socpra Sciences et Genie S.E.C.
    Inventors: Éric Marsault, François Malouin, Félix Chagnon, Isabelle Guay, Simon Boulanger
  • ATP SYNTHASE INHIBITORS AND STEROID ALKALOIDS AND USES THEREOF AS ANTIMICROBIAL AGENTS AND AS POTENTIATORS FOR AMINOGLYCOSIDES AGAINST PATHOGENIC BACTERIA
    Publication number: 20160317556
    Abstract: The present invention provides bacterial ATP synthase inhibitors such as a compound of formula (I): (Formula (I)) (A) in combination with an aminoglycoside antibiotic for preventing or treating a bacterial infection in a subject; or (B) (a) for preventing or treating an infection caused by an electron transport-deficient bacteria in a subject; or (b) for the disinfection, sterilization and/or antisepsis of an object contaminated with an electron transport-deficient bacteria. There are provided compositions and kits using such compounds and inhibitors.
    Type: Application
    Filed: December 23, 2014
    Publication date: November 3, 2016
    Inventors: ÉRIC MARSAULT, FRANÇOIS MALOUIN, FÉLIX CHAGNON, ISABELLE GUAY, SIMON BOULANGER
  • Steroid alkaloids and uses thereof as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria
    Patent number: 9457033
    Abstract: The present invention includes novel compounds based on the tomatidine skeleton as well as composition comprising these compounds alone and in combination with known compounds, which exhibit antimicrobial activity against extracellular or intracellular electron transport-deficient microbes and/or increase the antimicrobial activity of aminoglycoside antibiotics against their targets, and which are useful as antibacterial agents for treatment or prophylaxis of monomicrobiotic or polymicrobic bacterial infections or for the reduction of antibiotic resistance development in animals or in humans, or for use as antiseptics or agents for sterilization or disinfection.
    Type: Grant
    Filed: February 15, 2012
    Date of Patent: October 4, 2016
    Assignee: SOCPRA SCIENCES ET GENIE, S.E.C.
    Inventors: François Malouin, Gabriel Mitchell, Kamal Bouarab, Eric Marsault, Felix Chagnon, Simon Boulanger, Isabelle Guay
  • STEROID ALKALOIDS AND USES THEREOF AS ANTIMICROBIAL AGENTS AGAINST ELECTRON TRANSPORT-DEFICIENT MICROBES AND AS POTENTIATORS FOR ANTIMICROBIAL AGENTS AGAINST PATHOGENIC BACTERIA
    Publication number: 20140018312
    Abstract: The present invention includes novel compounds based on the tomatidine skeleton as well as composition comprising these compounds alone and in combination with known compounds, which exhibit antimicrobial activity against extracellular or intracellular electron transport-deficient microbes and/or increase the antimicrobial activity of aminoglycoside antibiotics against their targets, and which are useful as antibacterial agents for treatment or prophylaxis of monomicrobiotic or polymicrobic bacterial infections or for the reduction of antibiotic resistance development in animals or in humans, or for use as antiseptics or agents for sterilization or disinfection.
    Type: Application
    Filed: February 15, 2012
    Publication date: January 16, 2014
    Applicant: SOCPRA SCIENCES ET GENIE, S.E.C.
    Inventors: François Malouin, Gabriel Mitchell, Kamal Bouarab, Eric Marsault, Felix Chagnon, Simon Boulanger, Isabelle Guay